KOBE – A woman in her 70s being treated for an eye disease is making good progress a year after she underwent the world’s first transplant using iPS-derived cells, a team of researchers said Friday.
The team, comprising members from the Riken institute and the Institute of Biomedical Research and Innovation Hospital, successfully transplanted retinal cells grown from induced pluripotent stem cells to the woman.
If the operation is deemed safe, it could boost the use of iPS cells, which can grow into various human tissues, in treating ailments such as Parkinson’s disease, Alzheimer’s and other illnesses.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.